References
Hata M, Tsujikawa A, Miyake M et al (2015) Two-year visual outcome of polypoidal choroidal vasculopathy treated with photodynamic therapy combined with intravitreal injections of ranibizumab. Graefes Arch Clin Exp Ophthalmol 253:189–197
Tan CS, Ngo WK, Chen JP et al (2015) EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy. Br J Ophthalmol 99:624–628
Lim TH, Laude A, Tan CS (2010) Polypoidal choroidal vasculopathy: an angiographic discussion. Eye (Lond) 24:483–490
Tan CS, Heussen F, Sadda SR (2013) Peripheral autofluorescence and clinical findings in neovascular and non-neovascular age-related macular degeneration. Ophthalmology 120:1271–1277
Heussen FM, Tan CS, Sadda SR (2012) Prevalence of peripheral abnormalities on ultra-widefield greenlight (532 nm) autofluorescence imaging at a tertiary care center. Invest Ophthalmol Vis Sci 53:6526–6531
Tan CS, Ngo WK, Lim LW et al (2014) A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes. Br J Ophthalmol 98:1528–1533
American academy of ophthalmology (2014) Basic and clinical science course: retina and vitreous. American academy of ophthalmology, San Francisco, pp 65–66
Tan CS, Wong HT, Lim BA et al (2007) Polypoidal choroidal vasculopathy causing massive suprachoroidal haemorrhage. Eye (Lond) 21:132–133
Conflict of interest
Dr Colin Tan receives travel support from Bayer, Heidelberg Engineering, and Novartis. He also receives research support from the National Healthcare Group Clinician Scientist Career Scheme Grant (CSCS/12005).
Drs Wei Kiong Ngo and Louis W. Lim certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Dr Tock Han Lim receives travel support from Novartis and Heidelberg Engineering.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tan, C.S., Ngo, W.K., Lim, L.W. et al. Genetic influence on visual outcomes of polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 254, 1019–1020 (2016). https://doi.org/10.1007/s00417-015-3161-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-015-3161-5